Last reviewed · How we verify

NCT05189691

The Effect of Walking Exercises in Patients With Atrial Fibrillation

Completed NA Last updated 24 May 2023
What this trial tests

NA trial testing walking exercise in Atrial Fibrillation in 78 participants. Completed in 17 February 2023.

Timeline
4 April 2022
Primary endpoint
17 February 2023
17 February 2023

Quick facts

Lead sponsorNecmettin Erbakan University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment78
Start date4 April 2022
Primary completion17 February 2023
Estimated completion17 February 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Necmettin Erbakan University

Who can join

Adults 18 to 75, any sex, with Atrial Fibrillation or Quality of Life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research will be carried out to determine the effect of walking exercises performed using a behavioral change model on symptom severity and quality of life in patients with Atrial Fibrillation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Exercise-based cardiac rehabilitation for adults with atrial fibrillation.
    Buckley BJ, Long L, Risom SS, Lane DA, et al · · 2024 · cited 18× · PMID 39287086 · DOI 10.1002/14651858.cd011197.pub3

Verify or expand the search:

Other trials of walking exercise

Trials testing the same drug.

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Necmettin Erbakan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05189691.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing